SwePub
Sök i LIBRIS databas

  Extended search

L773:0966 3274 OR L773:1878 5492
 

Search: L773:0966 3274 OR L773:1878 5492 > IgM single antigen ...

IgM single antigen bead HLA-assay is affected by imlifidase through the cleavage of IgG but not IgM

Runstrom, Anna (author)
Hansa Biopharma AB, Box 785, SE-22007 Lund, Sweden.
Sjoholm, Kristoffer (author)
Hansa Biopharma AB, Box 785, SE-22007 Lund, Sweden.
Roupe, Karl Markus (author)
Hansa Biopharma AB, Box 785, SE-22007 Lund, Sweden.
show more...
Lorant, Tomas, 1975- (author)
Uppsala universitet,Transplantationskirurgi
Kjellman, Christian (author)
Hansa Biopharma AB, Box 785, SE-22007 Lund, Sweden.
Bockermann, Robert (author)
Hansa Biopharma AB, Box 785, SE-22007 Lund, Sweden.
show less...
Hansa Biopharma AB, Box 785, SE-22007 Lund, Sweden Transplantationskirurgi (creator_code:org_t)
Elsevier, 2021
2021
English.
In: Transplant Immunology. - : Elsevier. - 0966-3274 .- 1878-5492. ; 68
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Aim: The aim of this study was to investigate if human IgM is a cleavable substrate for imlifidase and to explain an observed effect in anti-HLA IgM single antigen bead (SAB) assays in sensitized patients. Methods: Serum samples collected pre-and 24 h post-imlifidase administration from sensitized patients enrolled in a phase II trial were investigated for anti-HLA IgG and IgM using SAB assays, with and without in vitro IgG depletion using a CaptureSelectTM affinity matrix. In addition, pre-dose samples and purified human IgM samples were treated with imlifidase in vitro and evaluated by SDS-PAGE, Western blot (PE-conjugated anti-human IgM) and SAB (IgG, IgM) assays. Results: By comparing the mean fluorescence intensity (MFI) of HLA-beads, pre-and post-imlifidase administration, three IgM-related patterns were observed; IgM-specific HLA-SABs with an increased MFI post-imlifidase, IgM-specific HLA-SABs with a decreased MFI post-imlifidase, and IgM-specific HLA-SABs with a marginal MFI difference between the pre-and post-imlifidase administration. These IgM signal patterns were observed despite neither purified IgM nor serum IgM could be cleaved by imlifidase. After removing IgG, the effects observed on anti-HLA IgM was largely eliminated with the biggest differences seen in patients with very high anti-HLA IgG in pre-dose samples. Conclusion: We demonstrate that imlifidase does not cleave human IgM, including HLA-specific IgM antibodies from highly sensitized subjects. Observed decreases of SAB-HLA IgM signals after imlifidase treatment may result from the cleavage of IgG-IgM complexes which are bound to SAB-HLA. Serum analysis of patients with high levels of anti-HLA IgG will result in a more accurate SAB-HLA IgM reading after IgG depletion.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Microbiology in the medical area (hsv//eng)

Keyword

Imlifidase
IgG-IgM complexes
SAB-HLA assay
Donor-specific IgG
Highly sensitized patients

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view